查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1855461

动物生长促进剂市场依产品种类、动物种类、用途、剂型、给药方法及通路划分－2025-2032年全球预测

Animal Growth Promoters Market by Product Type, Animal Type, Application, Form, Mode Of Administration, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，动物生长促进剂市场规模将达到 325.7 亿美元，复合年增长率为 8.89%。

关键市场统计数据
基准年 2024 164.7亿美元
预计年份：2025年 179.7亿美元
预测年份 2032 325.7亿美元
复合年增长率 (%) 8.89%

清晰、权威的指导，将动物生长促进剂置于决策者的监管压力、消费者期望和运作实际情况之中。

动物生长促进剂处于农业创新、动物健康管理和不断变化的社会期望的交汇点。这些物质和生物製药过去常用于提高饲料转换率、促进生长速度和降低疾病发生率，但如今正面临日益严格的监管审查和不断变化的消费者偏好。近年来，为了实现永续的生产力和市场认可，业内相关人员不得不重新评估其产品系列、投资重点和供应链韧性。

目前，从合成化合物到生物来源的饲料添加剂，各种活性干预措施层出不穷，每种措施都有不同的功效、给药方式和监管状态。专家必须权衡其功效与安全性、持久性问题以及抗菌素抗药性等长期影响。同时，酵素补充剂、植物添加剂、益生元和精准营养等替代方法因其既能提高动物生产性能又能满足消费者减少抗生素依赖的需求而日益受到关注。

因此，制定产品开发、商业化和市场进入策略需要对科学、监管趋势、相关人员的期望和分销动态有全面的了解。透过整体考虑这些方面，企业可以提供既满足种植者需求又符合公共卫生和永续性目标的产品，从而在复杂的商业环境中创造可持续的竞争优势。

监管、科学和供应链韧性的关键曲折点正在重塑整个产业的产品开发和商业策略。

近期趋势正在带来变革性变化，重新定义动物生长促进剂的研发、监管和在生产系统中的应用方式。首先，监理环境趋于谨慎，政策制定者日益重视公共卫生和环境因素。这一趋势迫使企业加快非抗生素替代品的创新，并投资于完善的安全性和残留数据。其次，供应链韧性已成为一项策略重点，因为饲料原料和活性物质的供应中断凸显了供应链的脆弱性，并促使企业更加关注在地采购、配方灵活性和多供应商策略。

第三，微生物组研究和酵素技术的科学进步使得更有针对性的干预措施成为可能，这些措施无需依赖传统的抗生素生长促进剂即可改善营养利用率和免疫功能。这些创新与诊断和数据分析技术的进步相辅相成，从而实现了农场层面的精准给药和性能追踪。第四，买家和消费者的期望日趋成熟。生产过程的透明度以及关于动物福利和产品安全性的检验声明，如今已成为众多价值链中获得商业性认可的关键。

总而言之，这些变化正在促使研发重点、商业策略和伙伴关係模式进行重新调整。那些将监管前瞻性、科学差异化和供应链适应性纳入策略规划的公司，将能够更好地掌握当前变革带来的机会；而那些适应缓慢的公司则可能面临更大的市场和声誉风险。

2025 年关税措施如何重塑全球采购优先事项、营运合规负担以及价值链中本地生产的策略奖励

美国2025年关税的实施和执行对全球畜牧业供应链产生了连锁反应，迫使製造商、经销商和生产商调整其采购、定价和库存策略。出口商和进口商重新调整了供应商关係以减轻关税的影响，加快了向替代采购市场的多元化发展，并引发了关于关键投入品在本土生产和近岸外包的讨论。这些调整不仅限于商业性；它们也影响了企业的产品组合决策，因为企业需要评估哪些产品在新成本结构下具有商业性可行性，哪些产品需要重新製造或在地化生产。

此外，关税引发的摩擦加重了跨境贸易的行政负担，迫使企业加强海关合规能力并重新谈判合约。小型生产商和供应商受到营运复杂性的影响尤其显着，因为他们难以承担额外的成本或迅速重组供应链。因此，依赖进口中间产品的某些分销管道和产品形式的销售成长放缓，需要其他商业策略，例如延长前置作业时间和合併发货。

同时，贸易伙伴和国内相关人员的政策应对措施包括旨在增强本地生产能力和降低进口依赖性的激励和支持措施。这些政策转变鼓励了配方技术的投资，并促进了目标地区生产规模的扩大。总而言之，2025年关税的累积影响凸显了供应链敏捷性、合规性和商业性灵活性对于动物生长促进剂生态系统内企业策略的重要性。

提供全面的细分洞察，以明确产品类型、物种特定需求、应用、配方、给药途径和通路等方面的策略方向

深入的产品细分有助于在整个动物生长促进剂领域内，针对产品开发、商业性执行和监管规划进行更精准的策略思考。考虑到Aminoglycosides、大环内酯类、青霉素类、四环霉素类等）、酵素（碳水化合物酶、植酸酶、蛋白酶等）、荷尔蒙（雄性激素、雌激素、黄体素、生长激素等）、植物源性促进生长剂（离子载体、精油、双叉桿菌萃取、香辛料等）以及益生元（果寡糖、半乳寡糖、甘露聚醣等）等微生物类产品，每种产品都面临着不同的商业性和监管方面的考量。每类产品都有其自身的证据要求、给药方案以及获得兽医和生产者认可的途径。

同样重要的是按动物类型区分，水生动物、牛、家禽和猪的干预措施需满足不同的性能预期和法律规范。疾病预防、生长促进和繁殖均需特定的疗效资料、安全性监测和给药策略。剂型（颗粒、液体、丸剂或粉末）的选择会影响饲料掺入率、稳定性以及农场操作偏好，而给药方式（饲料添加剂、注射剂或水添加剂）则会影响合规性、劳动力需求和成本结构。

最后，分销管道的动态至关重要。直销、分销商、线上零售平台和兽医诊所的市场管道、服务要求和利润预期各不相同。整合这些细分维度有助于更精准地进行产品设计、註册计画和市场推广策略，进而提高产品在产业不同细分领域的接受度和商业性成功率。

区域动态和政策细微差别将决定世界主要地区的产品采纳、监管合规路径和商业策略。

区域动态持续对动物生长促进剂的使用演变、监管方式和商业机会产生重大影响。在美洲，政策方针和消费者需求推动了创新和监管，重点关注负责任的使用、可追溯性以及开发符合出口要求的替代品。该地区庞大的一体化生产体係正在推动效率提升和技术应用，而贸易政策的发展则影响着筹资策略和生产布局。

欧洲、中东和非洲地区法律规范和市场结构的差异导致了不同的应用模式。欧洲司法管辖区往往采用严格的核准流程，并优先考虑抗生素管理，从而加速非抗生素解决方案的推广，并要求提供严谨的证据。中东和非洲市场法规环境和需求特征的多样性，既带来了挑战，也为客製化产品和分销模式提供了独特的机会。

亚太地区畜牧业和水产养殖业的快速密集发展，以及不断演变的监管标准和强劲的消费市场，显着推动了对性能提升和疾病控制工具的需求。为因应这些动态，本地创新和区域製造能力不断提升，而贸易政策的波动和投入品供应情况也持续影响商业策略。了解这些区域差异对于优先投资、协调监管文件以及製定符合当地生产者实际情况的分销和行销策略至关重要。

传统监管实力、专业生物技术创新以及市场准入合作模式之间的竞争动态将塑造该领域未来的领导地位。

动物生长促进剂市场的竞争格局呈现出多元化的特点，既有拥有深厚监管经验的传统企业，也有专注于生物替代品的利基专家，还有利用微生物组科学和精准营养技术的新兴创新者。老字型大小企业规模、监管备案和强大的分销网络，能够更广泛地市场进入，并与一体化生产商和饲料製造商保持持续的合作关係。同时，专注于酵素製剂、植物萃取物、益生元和益生菌的专业公司则凭藉其差异化的功效和与动物福利目标的更紧密契合，经常与饲料整合商和兽医服务机构合作，以加速产品推广应用。

创新正变得越来越注重协作，营养品公司、生物技术公司和通路合作伙伴之间正在建立跨行业的伙伴关係，这些合作伙伴能够将配方专业知识与深刻的客户洞察相结合。这些伙伴关係有助于加快产品组合的上市速度，并能够在真实的生产环境中产生更可靠的证据。此外，製造地和供应链的可靠性仍然是一项策略差异化因素。能够确保活性成分和成品配方品质稳定、供应及时的公司将保持竞争力，尤其是在贸易壁垒和原材料波动的情况下。

最后，企业策略涵盖了从加大监管科学领域的投入到进行有针对性的收购，以拓展高成长产品类型的产品组合。对于决策者而言，如何合理配置内部研发、外部合作和通路拓展，将决定能否将科学优势转化为商业性效益，同时满足监管机构和终端消费者日益增长的期望。

产业领导者现在可以采取哪些具有高影响力的策略行动，以确保供应链韧性、监管应对力和差异化的商业性价值提案？

产业领导者应优先考虑一系列切实可行的倡议，以平衡短期韧性和长期差异化优势。首先，加快对替代技术的投资，以减少对传统抗生素的依赖，并将可靠的疗效测试与真实世界的临床试验相结合，从而增强兽医和生产者的信心。其次，加强供应链并实现供应商多元化，评估关键投入品的离岸生产方案，并实施库存和物流，最大限度地降低关税和贸易风险。

第三，增加对监管情报的投入，并积极与监管机构沟通，将简化审批流程，确保产品声明在不同司法管辖区均具有说服力。第四，深化与饲料整合商、兽医服务提供者和数位农业平台的合作，打造将产品与咨询服务和绩效监测结合的捆绑式解决方案。此类整合式解决方案能够降低农场营运的复杂性，并带来可衡量的成果，从而加速产品的推广应用。

第五，加强透明度和认证途径，以满足消费者和买家对负责任使用和动物福利的期望。第六，将先进的分析和农场诊断技术融入商业性提案，精准给药，并在农场层级展现价值。采取这些措施将使企业能够应对监管方面的挑战，充分利用科学进步，并在充满机会和挑战的环境中满足相关人员的期望。

采用严谨的混合研究途径，结合专家访谈、监管分析和证据综合，提供可操作的业界考察。

本执行摘要的研究是基于多方面的证据，以确保分析的全面性和平衡性。关键的定性资料包括对价值链各环节专家的访谈，涵盖製剂科学家、法规专家、商业负责人、兽医和分销合作伙伴。这些访谈提供了关于产品功效、註册途径、市场接受度趋势和通路经济效益的实用观点。二级资讯来源包括同行评审文献、监管指导文件和技术白皮书，这些资料阐述了与动物生长促进相关的安全性、作用机制和新兴技术。

我们的分析方法结合了定性见解的主题综合分析和对监管环境及贸易政策发展的系统性回顾。我们专注于对不同地区的研究结果进行三角验证，以识别一致的模式和区域差异。这种方法强调假设的透明度，仔细区分不同产品类别的证据级别，并明确考虑影响产品采用的营运和商业限制。在整个调查方法中，我们力求在科学严谨性和对决策者的实际意义之间取得平衡，以满足其在产品组合策略、监管规划和市场准入执行方面的需求。

策略总结重点阐述了科学进步、监管变化和供应链灵活性将如何决定该领域的竞争优势。

总体而言，在不断变化的法规、科学创新以及商业性和消费者期望的推动下，动物生长促进剂市场正在经历一场变革。传统的抗生素类生长促进剂正日益受到生物来源的性能增强替代品的竞争，后者承诺在不引发公共卫生问题的情况下提高营养利用率和疾病抵抗力。同时，贸易政策和关税措施的调整也凸显了供应链弹性和在地化生产方案的战略重要性。

对于相关人员，未来发展的关键在于将科学差异化与稳健的监管策略结合，并建立通路伙伴关係，从而降低农场层面的推广门槛。那些致力于投资经验证的替代方案、确保供应链多元化并提供产品、咨询服务和分析相结合的捆绑式解决方案的企业，将能够更好地掌握商业机会，同时满足日益增长的监管和透明度要求。相反，那些仅依赖传统方法而不适应新的监管和市场现实的公司，则可能面临营运和声誉方面的挑战。未来，那些兼具卓越技术、策略敏捷性和相关人员参与度的企业，必将获得产业回报。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 利用精准发酵技术生产不含抗生素的牲畜用生物活性生长促进剂
  • 植物性饲料添加剂创新层出不穷，旨在改善单胃动物的肠道健康和生产性能。
  • 开发针对特异性的益生菌配方，以优化家禽的营养吸收和免疫反应
  • 抗生素生长促进剂的监管逐步淘汰将推动对替代酶和有机酸解决方案的需求。
  • 将体外输注技术应用于商品雏鸡的早期生长促进和免疫调节。
  • 在各种养殖条件下，越来越多地采用蛋白质水解物补充剂来改善水产养殖物种的生长指标。
  • 推出多酵素混合物，可提高饲料转换率并减少牲畜氮磷排泄。

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：依产品类型分類的动物生长促进剂市场

  • 抗生素
    • Aminoglycosides
    • 大环内酯类
    • 青霉素
    • 四环霉素
  • 酵素
    • 碳水化合物降解酶
    • 植酸酶
    • 蛋白酶
  • 荷尔蒙
    • 雄激素
    • 雌激素
    • 孕酮
    • Somatropin
  • 离子载体
  • 植物源
    • 精油
    • 草药萃取物
    • 香辛料
  • 益生元
    • 果寡糖
    • 半乳寡糖
    • 甘露聚醣
  • 益生菌
    • 芽孢桿菌
    • 双歧桿菌
    • 乳酸菌

9. 依动物类型分類的动物生长促进剂市场

  • 水生动物
  • 牛
  • 家禽
  • 猪

第十章：按应用分類的动物生长促进剂市场

  • 疾病预防
  • 促进生长
  • 选育

第十一章：动物生长促进剂市场（依剂型划分）

  • 颗粒
  • 液体
  • 颗粒
  • 粉末

第十二章：按剂型分類的动物生长促进剂市场

  • 饲料添加剂
  • 注射
  • 水添加物

第十三章：依通路分類的动物生长促进剂市场

  • 直销
  • 经销商
  • 线上零售
  • 兽医诊所

第十四章 按地区分類的动物生长促进剂市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 动物生长促进剂市场（依类别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章：各国动物生长促进剂市场概况

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Archer Daniels Midland Company
    • Cargill, Incorporated
    • BASF SE
    • Koninklijke DSM NV
    • Evonik Industries AG
    • Novus International, Inc.
    • Kemin Industries, Inc.
    • Alltech, Inc.
    • Phibro Animal Health Corporation
    • Nutreco NV
Product Code: MRR-C803CE17101F

The Animal Growth Promoters Market is projected to grow by USD 32.57 billion at a CAGR of 8.89% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.47 billion
Estimated Year [2025] USD 17.97 billion
Forecast Year [2032] USD 32.57 billion
CAGR (%) 8.89%

A clear and authoritative orientation that frames animal growth promoters within regulatory pressures, consumer expectations, and operational realities for decision-makers

Animal growth promoters sit at the intersection of agricultural innovation, animal health management, and evolving public expectations. Historically deployed to improve feed efficiency, accelerate growth rates, and reduce disease incidence, these substances and biologicals have become subject to heightened regulatory scrutiny and shifting consumer preferences. Over recent years, industry actors have been compelled to reassess product portfolios, investment priorities, and supply chain resilience as pathways to sustainable productivity and market acceptance.

The landscape encompasses a diverse set of active interventions, from synthetic compounds to biologically derived feed supplements, each bringing distinct efficacy profiles, administration modes, and regulatory pathways. Practitioners must weigh efficacy against safety, residue concerns, and long-term impacts such as antimicrobial resistance. At the same time, alternative approaches like enzyme supplementation, phytogenic additives, prebiotics, and precision nutrition are gaining attention for their ability to support performance while aligning with consumer demands for reduced antibiotic dependence.

Consequently, strategic planning for product development, commercialisation, and market access requires an integrated understanding of science, regulatory trends, stakeholder expectations, and distribution dynamics. By considering these dimensions together, organisations can position offerings that meet producer needs for performance while addressing public health and sustainability objectives, thereby creating durable competitive advantages in a complex operating environment.

Critical inflection points in regulation, science, and supply chain resilience that are reshaping product development and commercial strategies across the sector

Recent years have produced transformative shifts that are redefining how animal growth promoters are developed, regulated, and adopted across production systems. First, regulatory landscapes have moved toward greater precaution, with policymakers increasingly prioritising public health outcomes and environmental considerations; this trend has forced companies to accelerate innovation in non-antibiotic alternatives and to invest in robust safety and residue data packages. Second, supply chain resilience has become a strategic priority, as disruptions in feed ingredients and active materials have highlighted vulnerabilities and driven interest in local sourcing, formulation flexibility, and multi-supplier strategies.

Third, scientific advances in microbiome research and enzyme technologies are enabling more targeted interventions that improve nutrient utilisation and immune function without relying on traditional antibiotic growth promoters. These innovations are complemented by improved diagnostics and data analytics, which permit precision dosing and performance tracking at the farm level. Fourth, buyer and consumer expectations have matured; transparency in production practices and verifiable claims about animal welfare and product safety are now central to commercial acceptance in many value chains.

Taken together, these shifts are prompting a reconfiguration of R&D priorities, commercial strategies, and partnership models. Firms that integrate regulatory foresight, scientific differentiation, and supply chain adaptability into their strategic plans are better positioned to capture opportunities amid ongoing transformation, while those that delay adaptation may face increasing market and reputational risks.

How 2025 tariff actions recalibrated global sourcing priorities, operational compliance burdens, and strategic incentives for local manufacturing across the value chain

The introduction and escalation of tariffs by the United States in 2025 created a ripple effect across global supply chains that support animal growth promoters, prompting manufacturers, distributors, and producers to adjust sourcing, pricing structures, and inventory practices. Exporters and importers recalibrated supplier relationships to mitigate tariff exposure, which accelerated diversification toward alternative sourcing markets and stimulated conversations about on-shore manufacturing and near-shoring for critical inputs. These adaptations were not solely commercial; they also influenced portfolio decisions as companies evaluated which products remained commercially viable under new cost structures and which required reformulation or localisation.

In addition, tariff-induced friction increased the administrative burden for cross-border transactions, necessitating more robust customs compliance capabilities and contract renegotiations. This operational complexity was felt most strongly by smaller producers and suppliers with limited capacity to absorb added costs or to reconfigure supply chains rapidly. As a result, certain distribution channels and product formats that depend on imported intermediates experienced slower turnover and required alternative commercial tactics, such as longer lead times and consolidated shipments.

At the same time, policy responses from trade partners and domestic stakeholders included incentives and support measures aimed at bolstering local manufacturing capacity and reducing import dependency. These policy shifts encouraged investment into formulation technologies and manufacturing scale-up in target geographies. In sum, the cumulative impact of tariffs in 2025 reinforced the strategic importance of supply chain agility, regulatory compliance, and commercial flexibility for organisations operating within the animal growth promoter ecosystem.

Comprehensive segmentation insights that align product types, species-specific needs, application contexts, formulations, administration routes, and distribution pathways for strategic clarity

Insightful segmentation enables more precise strategic thinking about product development, commercial execution, and regulatory planning across the animal growth promoter domain. When products are considered by type-covering antibiotics such as aminoglycosides, macrolides, penicillins, and tetracyclines; enzymes including carbohydrase, phytase, and protease; hormones spanning androgens, estrogens, progesterones, and somatotropins; ionophores; phytogenics comprising essential oils, herbal extracts and spices; and microbiome-focused options such as prebiotics like fructo oligosaccharides, galacto oligosaccharides, and mannan oligosaccharides alongside probiotics exemplified by Bacillus, Bifidobacterium and Lactobacillus-distinct commercial and regulatory considerations emerge. Each product family implies unique evidence requirements, administration protocols, and pathways to acceptance among veterinarians and producers.

Equally important is differentiation by animal type, where interventions for aquatic animals, cattle, poultry and swine follow divergent performance expectations and regulatory frameworks. Application context further modifies strategic priorities: disease prevention, growth promotion, and reproduction each call for specific efficacy data, safety monitoring, and dosing strategies. Form selection-granules, liquid, pellets and powder-affects feed integration, stability, and on-farm handling preferences, while mode of administration through feed additives, injectables or water additives influences compliance, labor requirements, and cost structures.

Finally, distribution dynamics matter: direct sales, distributors, online retail platforms and veterinary hospitals each offer different routes to market, service requirements, and margin expectations. Integrating these segmentation dimensions enables sharper targeting of product design, registration planning, and go-to-market approaches, thereby increasing the likelihood of adoption and commercial success in distinct subsegments of the industry.

Regional dynamics and policy nuances that determine product adoption, regulatory compliance pathways, and commercial strategies across key global territories

Regional dynamics continue to exert significant influence on the evolution of animal growth promoter use, regulatory approaches, and commercial opportunities. In the Americas, policy approaches and consumer demands have driven both innovation and scrutiny, with a strong emphasis on responsible use, traceability, and the development of alternatives that meet export requirements. This region's large and integrated production systems have incentivised efficiency gains and technological adoption, while trade policy developments have influenced sourcing strategies and manufacturing footprints.

Across Europe, the Middle East and Africa, regulatory frameworks and market structures are heterogeneous, resulting in varied adoption patterns. European jurisdictions tend to apply stringent approval processes and to prioritise antimicrobial stewardship, which has accelerated uptake of non-antibiotic solutions and generated rigorous evidence expectations. Markets in the Middle East and Africa present diverse regulatory environments and demand profiles that create both challenges and niche opportunities for tailored products and distribution models.

In the Asia-Pacific region, rapid intensification of livestock and aquaculture production, coupled with evolving regulatory standards and strong consumer markets, has driven substantial demand for performance-enhancing and disease-management tools. Local innovation and regional manufacturing capacity have expanded in response to these dynamics, while fluctuating trade policies and input availability continue to shape commercial strategies. Understanding these regional nuances is essential for prioritising investment, tailoring regulatory dossiers, and designing distribution and marketing tactics that reflect local producer realities.

Competitive dynamics that blend legacy regulatory strength, specialist biological innovation, and collaborative go-to-market models shaping future leadership in the sector

The competitive landscape of animal growth promoters is characterised by a mix of legacy players with deep regulatory experience, niche specialists focused on biologically derived alternatives, and emerging innovators leveraging microbiome science and precision nutrition. Established firms benefit from scale, regulatory dossiers, and entrenched distribution networks, which facilitate broad market access and ongoing engagement with integrated producers and feed manufacturers. At the same time, specialist companies that concentrate on enzymes, phytogenics, prebiotics, and probiotics are capitalising on differentiated efficacy profiles and stronger alignment with stewardship objectives, often partnering with feed integrators and veterinary services to accelerate adoption.

Innovation is increasingly collaborative, with cross-sector partnerships between nutrition companies, biotechnology firms, and channel partners that can combine formulation expertise with deep customer insights. These partnerships support faster route-to-market for combinations of products and enable more credible evidence generation in real-world production settings. Additionally, manufacturing footprint and supply chain reliability remain strategic differentiators; firms that can assure consistent quality and timely delivery of active ingredients and finished formulations maintain a competitive edge, particularly when trade barriers or raw material volatility are present.

Finally, corporate strategies vary from deepening investments in regulatory science to pursuing targeted acquisitions that broaden portfolios in high-growth product categories. For decision-makers, identifying the right mix of internal R&D, external partnerships, and channel development will determine the capacity to convert scientific advantage into commercial performance while meeting heightened expectations from regulators and end consumers.

High-impact strategic actions that industry leaders can implement now to secure supply resilience, regulatory readiness, and differentiated commercial value propositions

Industry leaders should prioritise a set of actionable initiatives that balance near-term resilience with long-term differentiation. First, accelerate investment in alternative technologies that reduce reliance on traditional antibiotics, pairing robust efficacy studies with real-world trials to build credibility among veterinarians and producers. Second, strengthen supply chain strategies by diversifying suppliers, evaluating near-shore manufacturing options for critical inputs, and instituting inventory and logistics practices that minimise tariff and trade risk exposure.

Third, invest in regulatory intelligence and preemptive engagement with authorities to streamline approvals and to ensure that product claims are defensible across jurisdictions. Fourth, deepen partnerships with feed integrators, veterinary service providers and digital agriculture platforms to create bundled solutions that combine products with advisory services and performance monitoring. These integrated offerings can accelerate adoption by reducing on-farm complexity and by delivering measurable outcomes.

Fifth, enhance transparency and certification pathways that respond to consumer and buyer expectations about responsible use and animal welfare, using validated protocols to substantiate claims. Sixth, embed advanced analytics and on-farm diagnostics into commercial propositions to enable precision dosing and to demonstrate value at the farm level. Executed together, these actions will position organisations to manage regulatory headwinds, to capitalise on scientific progress, and to meet evolving stakeholder expectations in a contested yet opportunity-rich environment.

A rigorous mixed-methods research approach combining expert interviews, regulatory analysis, and evidence synthesis to produce actionable industry insights

The research underpinning this executive summary combines multiple evidence streams to ensure comprehensive and balanced analysis. Primary qualitative inputs included interviews with subject matter experts across the value chain, encompassing formulation scientists, regulatory specialists, commercial leaders, veterinarians, and distribution partners. These conversations provided practical perspectives on product efficacy, registration pathways, adoption dynamics, and channel economics. Secondary sources encompassed peer-reviewed literature, regulatory agency guidance documents, and technical white papers that elucidate safety profiles, mechanisms of action, and emerging technologies relevant to animal growth promotion.

Analytical methods integrated thematic synthesis of qualitative insights with systematic review of regulatory contexts and trade policy developments. Attention was given to triangulating findings from different geographies to identify consistent patterns and region-specific divergences. The approach emphasised transparency in assumptions, careful differentiation between evidence levels across product classes, and explicit consideration of operational and commercial constraints that influence adoption. Throughout, the methodology sought to balance scientific rigor with practical relevance for decision-makers focused on portfolio strategy, regulatory planning, and go-to-market execution.

A strategic closing synthesis highlighting how scientific advancement, regulatory shifts, and supply chain agility will determine competitive advantage in the sector

In aggregate, the animal growth promoter landscape is undergoing a period of purposeful transition driven by regulatory evolution, scientific innovation, and shifting commercial and consumer expectations. Traditional antibiotic-based growth promotion is increasingly juxtaposed with biologically derived and performance-enhancing alternatives that promise improved nutrient utilisation and disease resilience without the same public health concerns. Concurrently, trade policy shifts and tariff actions have underscored the strategic importance of supply chain agility and local manufacturing options.

For stakeholders, the path forward involves integrating scientific differentiation with robust regulatory strategies and channel partnerships that reduce barriers to adoption at the farm level. Organisations that move decisively to invest in validated alternatives, to secure diversified supply chains, and to offer bundled solutions that combine product, advisory services, and analytics will be better positioned to capture commercial opportunities while meeting heightened expectations for stewardship and transparency. In contrast, firms that rely solely on legacy approaches without adapting to emerging regulatory and market realities are likely to encounter increasing operational and reputational challenges. The future of the sector will reward those who combine technical excellence with strategic agility and stakeholder engagement.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of precision fermentation techniques to produce antibiotic-free bioactive growth promoters for livestock
  • 5.2. Surge in innovation of phytogenic feed additives to enhance gut health and performance in monogastric animals
  • 5.3. Development of species-specific probiotic formulations to optimize nutrient absorption and immune response in poultry
  • 5.4. Regulatory phase-out of antibiotic growth promoters driving demand for alternative enzyme and organic acid solutions
  • 5.5. Integration of in ovo injection technologies for early-stage growth promotion and immunomodulation in commercial chicks
  • 5.6. Rising adoption of protein hydrolysate-based supplements to improve growth metrics in aquaculture species under varied farming conditions
  • 5.7. Emergence of tailored multi-enzyme blends to improve feed conversion efficiency and reduce nitrogen and phosphorus excretion in livestock

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Animal Growth Promoters Market, by Product Type

  • 8.1. Antibiotics
    • 8.1.1. Aminoglycosides
    • 8.1.2. Macrolides
    • 8.1.3. Penicillins
    • 8.1.4. Tetracyclines
  • 8.2. Enzymes
    • 8.2.1. Carbohydrase
    • 8.2.2. Phytase
    • 8.2.3. Protease
  • 8.3. Hormones
    • 8.3.1. Androgens
    • 8.3.2. Estrogens
    • 8.3.3. Progesterones
    • 8.3.4. Somatotropins
  • 8.4. Ionophores
  • 8.5. Phytogenics
    • 8.5.1. Essential Oils
    • 8.5.2. Herbal Extracts
    • 8.5.3. Spices
  • 8.6. Prebiotics
    • 8.6.1. Fructo Oligosaccharides
    • 8.6.2. Galacto Oligosaccharides
    • 8.6.3. Mannan Oligosaccharides
  • 8.7. Probiotics
    • 8.7.1. Bacillus
    • 8.7.2. Bifidobacterium
    • 8.7.3. Lactobacillus

9. Animal Growth Promoters Market, by Animal Type

  • 9.1. Aquatic Animals
  • 9.2. Cattle
  • 9.3. Poultry
  • 9.4. Swine

10. Animal Growth Promoters Market, by Application

  • 10.1. Disease Prevention
  • 10.2. Growth Promotion
  • 10.3. Reproduction

11. Animal Growth Promoters Market, by Form

  • 11.1. Granules
  • 11.2. Liquid
  • 11.3. Pellets
  • 11.4. Powder

12. Animal Growth Promoters Market, by Mode Of Administration

  • 12.1. Feed Additive
  • 12.2. Injectable
  • 12.3. Water Additive

13. Animal Growth Promoters Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Distributors
  • 13.3. Online Retail
  • 13.4. Veterinary Hospitals

14. Animal Growth Promoters Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Animal Growth Promoters Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Animal Growth Promoters Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Archer Daniels Midland Company
    • 17.3.2. Cargill, Incorporated
    • 17.3.3. BASF SE
    • 17.3.4. Koninklijke DSM N.V.
    • 17.3.5. Evonik Industries AG
    • 17.3.6. Novus International, Inc.
    • 17.3.7. Kemin Industries, Inc.
    • 17.3.8. Alltech, Inc.
    • 17.3.9. Phibro Animal Health Corporation
    • 17.3.10. Nutreco N.V.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. ANIMAL GROWTH PROMOTERS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. ANIMAL GROWTH PROMOTERS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ANIMAL GROWTH PROMOTERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MACROLIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PENICILLINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY TETRACYCLINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CARBOHYDRASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROTEASE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANDROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESTROGENS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROGESTERONES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SOMATOTROPINS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY IONOPHORES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ESSENTIAL OILS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HERBAL EXTRACTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SPICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FRUCTO OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GALACTO OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MANNAN OLIGOSACCHARIDES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PROBIOTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BACILLUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY BIFIDOBACTERIUM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LACTOBACILLUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANIMAL TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY AQUATIC ANIMALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY CATTLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POULTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SWINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISEASE PREVENTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GROWTH PROMOTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REPRODUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FORM, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY GRANULES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY LIQUID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PELLETS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY POWDER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY FEED ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY WATER ADDITIVE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ONLINE RETAIL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY VETERINARY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ANIMAL GROWTH PROMOTERS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 302. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 303. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 306. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ANTIBIOTICS, 2025-2032 (USD MILLION)
  • TABLE 307. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
  • TABLE 308. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY ENZYMES, 2025-2032 (USD MILLION)
  • TABLE 309. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2018-2024 (USD MILLION)
  • TABLE 310. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY HORMONES, 2025-2032 (USD MILLION)
  • TABLE 311. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2018-2024 (USD MILLION)
  • TABLE 312. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PHYTOGENICS, 2025-2032 (USD MILLION)
  • TABLE 313. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY PREBIOTICS, 2018-2024 (USD MILLION)
  • TABLE 314. AMERICAS ANIMAL GROWTH PROMOTERS MARKET SIZE, BY